1. Stocks
  2. Aarti Drugs Ltd.
  3. Swot
swot-logo

Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aarti Drugs Ltd. has 15 Strengths, 7 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Decline in Quarterly Net Profit (YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Top Losers

FII / FPI or Institutions increasing their shareholding

Weekly Momentum Gainers

MFs increased their shareholding last quarter

Red Flag: Companies seeing significant coronavirus impact

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)